Business

ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504

SILICON VALLEY, CA - May 9, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indication...

articleAbvc Biopharma, Inc.May 9, 20256/company/abvc-biopharma-inc/news/abvc-biopharma-secures-japanese-patent-130000517
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504

About this update from Abvc Biopharma, Inc.

[{"type":"image","caption":"","headline":"ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States","size":{"original":{"width":140,"height":78,"url":"https://media.zenfs.com/en/newsmediawire_165/abacbb2aeeae890aef297a130fea97c7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/X_qKvHxujBtXyrHhszohog--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTExNztjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/abacbb2aeeae890aef297a130fea97c7","width":140,"height":78}}},{"type":"text","content":"SILICON VALLEY, CA - May 9, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced that the Japan Patent Office has granted a new patent protection for its Major Depressive Disorder (MDD) candidate, ABV-1504. The patent, valid through 2040, strengthens ABVC's global intellectual property portfolio for PDC-1421, the active botanical ingredient in ABV-1504. The compound is now protected in four major territories as shown below:","length":619,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"padding:0cm 5.4pt;width:19.1241%;text-align:left;vertical-align:middle;","val":[{"type":"text","content":"Country","length":7,"tagName":"p"}]},{"style":"border-bottom-color:windowtext;padding:0cm 5.4pt;width:32.9427%;text-align:left;vertical-align:middle;","val":[{"type":"text","content":"Patent Number / Application No.","length":31,"tagName":"p"}]},{"style":"width:22.4914%;border-bottom-color:windowtext;padding:0cm 5.4pt;text-align:left;vertical-align:middle;","val":[{"type":"text","content":"Status","length":6,"tagName":"p"}]},{"style":"width:25.5021%;border-bottom-color:windowtext;padding:0cm 5.4pt;text-align:left;vertical-align:middle;","val":[{"type":"text","content":"Valid Through","length":13,"tagName":"p"}]}]},{"val":[{"style":"border-bottom-color:windowtext;padding:0cm 5.4pt;width:19.1241%;text-align:left;vertical-align:middle;","val":[{"type":"text","content":"United States","length":13,"tagName":"p"}]},{"style":"border-bottom-color:windowtext;padding:0cm 5.4pt;width:32.9427%;text-align:left;vertical-align:middle;","val":[{"type":"text","content":"US 11,554,154 B2","length":16,"ta...

More updates from Abvc Biopharma, Inc.

Japan Patent OfficeABVCBioPharmabiopharmaceutical companypatent protectionThe Company